US 7427630
Condensed N-heterocyclic compounds and their use as CRF receptor antagonists
granted A61PA61P1/02A61P1/04
Quick answer
US patent 7427630 (Condensed N-heterocyclic compounds and their use as CRF receptor antagonists) held by Neurocrine Biosciences, Inc. expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Neurocrine Biosciences, Inc.
- Grant date
- Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P1/02, A61P1/04, A61P1/08, A61P1/14